We found that markers associated with angiogenesis were enriched in dogs with short remissions whereas multiple T cell transcripts, including IL2RB, were enriched in dogs with exceptional responses to CHOP, the latter of which is also associated with prolonged survival in human DLBCL patients. This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.